Cohen Capital Management, Inc. - HERON THERAPEUTICS INC ownership

HERON THERAPEUTICS INC's ticker is HRTX and the CUSIP is 427746102. A total of 204 filers reported holding HERON THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is 2.25 and the average weighting 0.5%.

Quarter-by-quarter ownership
Cohen Capital Management, Inc. ownership history of HERON THERAPEUTICS INC
ValueSharesWeighting
Q4 2019$3,345,000
+27.0%
142,3300.0%0.72%
+19.8%
Q3 2019$2,633,000
-0.5%
142,3300.0%0.60%
-1.9%
Q2 2019$2,646,000
-23.6%
142,330
+0.4%
0.62%
-26.1%
Q1 2019$3,465,000
-5.8%
141,7800.0%0.84%
-18.0%
Q4 2018$3,678,000
-17.6%
141,780
+0.6%
1.02%
+1.3%
Q3 2018$4,463,000
-18.4%
141,000
+0.2%
1.00%
-20.6%
Q2 2018$5,467,000
+23.8%
140,710
+0.5%
1.27%
+22.0%
Q1 2018$4,417,000140,0001.04%
Other shareholders
HERON THERAPEUTICS INC shareholders Q2 2018
NameSharesValueWeighting ↓
TANG CAPITAL MANAGEMENT LLC 8,648,252$238,692,00035.08%
Broadfin Capital, LLC 1,581,416$43,647,0006.80%
Tavio Capital LLC 351,729$9,708,0004.58%
Mesirow Financial Investment Management, Inc. 33,389$922,0003.88%
Rubric Capital Management LP 1,510,008$41,676,0003.88%
KINGDON CAPITAL MANAGEMENT, L.L.C. 1,666,229$45,988,0003.63%
First Light Asset Management, LLC 473,275$13,062,0002.87%
Asymmetry Capital Management, L.P. 77,346$2,135,0002.67%
Copernicus Capital Management, LLC 108,000$2,981,0002.38%
BRIDGER MANAGEMENT, LLC 1,277,560$35,261,0002.14%
View complete list of HERON THERAPEUTICS INC shareholders